SNAKEAI ASSISTED MEDICAL DEVICES INC.

For decades, public awareness campaigns have highlighted the importance of early cancer detection. Yet, as of 2024, only 40% of colorectal cancer cases in the U.S. are detected early, primarily due to inefficiencies in traditional screening methods. Shockingly, 1 in 3 eligible individuals has never been screened. The reasons go beyond awareness—patients often cite fear of discomfort, the invasive nature of colonoscopies, and long wait times due to capacity constraints. SnakeAI is transforming this landscape with AI-powered robotic colonoscopy system. Designed with patient comfort and clinical efficiency in mind, SnakeAI addresses these barriers head-on. Our innovative technology enhances diagnostic accuracy, shortens procedure times, and offers a more comfortable, patient-friendly alternative to traditional methods. By making screenings smarter, faster, and less intimidating, SnakeAI empowers healthcare providers to save lives through earlier detection while optimizing system capacity and reducing costs. Our journey includes breakthrough design innovations, clinical collaborations, and a commitment to making colorectal cancer screening accessible and effective. Together, we can redefine early detection and reduce the burden of this preventable disease.

• Employees 1
• Founded 2023